Why the study?
Conventional right ventricular pacing can increase the risk of atrial fibrillation and heart failure, prompting the need to compare ECG changes induced by RVP and physiological left bundle branch area pacing.
Does left bundle branch area pacing improve ECG depolarization and repolarization markers compared to right ventricular pacing in patients with bradycardia?
Does left bundle branch area pacing improve ECG depolarization and repolarization markers compared to right ventricular pacing in patients with bradycardia?
LBBAP leads to more synchronized ventricular depolarization compared to RVP, supporting its potential to improve clinical outcomes in anti-bradycardia therapy.
LBBAP linked to better depolarization markers than RVP; hypothesis-generating for clinical outcomes in bradycardia pacing.
Patients suffering from bradycardia are indicated for pacemaker implantation. Right ventricular pacing (RVP) has been conventionally used for this purpose, but it can increase the risk of atrial fibrillation and heart failure. Left bundle branch area pacing (LBBAP) has been proposed as a new physiological pacing technique. The aim of this study was to compare changes induced by RVP and LBBAP in the ECG. 10-minute 12-lead ECG recordings were acquired at baseline and after pacemaker implantation from 83 patients (31 RVP, 52 LBBAP). Median beats were calculated for each patient at baseline and post-implantation states. ECG markers including QRS duration (dQRS) and area (aQRS) and heart rate-corrected QT (QTc) and Tpeak-to-Tend (Tpec) intervals were measured. dQRS and aQRS decreased significantly at post-implantation with respect to baseline, both being significantly lower for LB-BAP than RVP after pacemaker implantation. QTc was significantly reduced at post-implantation for both pacing techniques with no differences between them. Tpec did not change either between states or techniques. In conclusion, LBBAP led to more synchronized ventricular depolarization, supporting potentially improved clinical outcomes with LBBAP as compared to RVP for anti-bradycardia therapy.
No takes yet. Share an insight, caveat, or question.
Bellés et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: